CSF3 and acute myeloid leukemia: Aclarubicin-based chemotherapy protocols, Ara-C, aclarubicin, and G-CSF (CAG) regimen, have better efficacy and safety in initially diagnosed or RR-AML [31–33], which is based mainly on observations in adult AML.